Bone targeted EP4 Agonist as muscle anabolics In muscular dystrophy

The overarching project goal is to validate the compound’s use as a management strategy for muscular dystrophy, opening the path to its clinical testing in a rare disease and expanding its commercialization potential beyond bone-related conditions.

Faculty Supervisor:

Fabio Rossi

Student:

Partner:

Mesentech Inc

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

The University of British Columbia

Program:

Elevate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation
International

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe